Found: 5
Select item for more details and to access through your institution.
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 620, p. 1, doi. 10.1126/scitranslmed.abh0272
- By:
- Publication type:
- Article
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.
- Published in:
- Stem Cells, 2016, v. 34, n. 9, p. 2429, doi. 10.1002/stem.2415
- By:
- Publication type:
- Article
Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00069
- By:
- Publication type:
- Article
CHANGE-seq reveals genetic and epigenetic effects on CRISPR–Cas9 genome-wide activity.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 11, p. 1317, doi. 10.1038/s41587-020-0555-7
- By:
- Publication type:
- Article